Abstract:This study was designed to explore the binding mode of pefloxacin mesylate(PFLX) with human serum albumin (HSA). Fluorescence spectroscopic results showed pefloxacin-HSA complex with binding constants of 1.7 x 10(5) L (.) mol(-1). The, enthalpy change (Delta(r)H(m)) and entropy change (Delta(r)S(m)) were measured by microcalorimetry to be 1.03 kJ (.) mol(-1) and 101.28 J (.) K-1 (.) mol(-1), which indicated that hydrophobic interaction played a major role in the binding of PFLX with HSA. The possible binding domains of HSA for PFLX were studied by molecular modeling, which predicted that the hydrophobic interaction played a dominating role in this drug-protein interaction and PFLX could bind to Sudlow's sites I and II of HSA. The binding energies obtained from the molecular modeling were in accordance with the experiment results.

The Binding Mode of Pefloxacin Mesylate with Human Serum Albumin